Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Hepcidin: immunoanalytic characteristics.

Wolff F, de Verneuil H, Rucheton B, Lefebvre T, Vialaret J, Ropert-Bouchet M, Cunat S, Aguilar-Martinez P, Lehmann S, Delaby C.

Ann Biol Clin (Paris). 2018 Dec 1;76(6):705-715. doi: 10.1684/abc.2018.1382.

PMID:
30257815
2.

Impact of biological matrix on inflammatory protein biomarker quantification based on targeted mass spectrometry.

Incamps A, Saez-Boiteau C, Tiede SL, Rebillard P, Schulte J, Vialaret J, Beinrucker A, Lehmann S, Hirtz C.

Bioanalysis. 2018 Sep 1;10(17):1383-1399. doi: 10.4155/bio-2018-0149. Epub 2018 Sep 12.

PMID:
30207162
3.

Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches.

Vialaret J, Schmit PO, Lehmann S, Gabelle A, Wood J, Bern M, Paape R, Suckau D, Kruppa G, Hirtz C.

Data Brief. 2018 Mar 31;18:1013-1021. doi: 10.1016/j.dib.2018.03.114. eCollection 2018 Jun.

4.

Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods.

Hirtz C, Bros P, Brede C, Lescuyer P, Maceski AM, Vialaret J, Delatour V, Lehmann S; IFCC Working Group on Clinical Quantitative Mass Spectrometry Proteomics (WG-cMSP).

Crit Rev Clin Lab Sci. 2018 Aug;55(5):346-358. doi: 10.1080/10408363.2018.1470159. Epub 2018 May 23.

PMID:
29792094
5.

What sample preparation should be chosen for targeted MS monoclonal antibody quantification in human serum?

Vialaret J, Broutin S, Pugnier C, Santelé S, Jaffuel A, Barnes A, Tiers L, Pelletier L, Lehmann S, Paci A, Hirtz C.

Bioanalysis. 2018 May 1;10(10):723-735. doi: 10.4155/bio-2018-0027. Epub 2018 May 17.

PMID:
29771137
6.

Nano-flow vs standard-flow: Which is the more suitable LC/MS method for quantifying hepcidin-25 in human serum in routine clinical settings?

Vialaret J, Picas A, Delaby C, Bros P, Lehmann S, Hirtz C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jun 1;1086:110-117. doi: 10.1016/j.jchromb.2018.04.003. Epub 2018 Apr 10.

PMID:
29660664
7.

Association between serum hepcidin level and restless legs syndrome.

Dauvilliers Y, Chenini S, Vialaret J, Delaby C, Guiraud L, Gabelle A, Lopez R, Hirtz C, Jaussent I, Lehmann S.

Mov Disord. 2018 Apr;33(4):618-627. doi: 10.1002/mds.27287. Epub 2018 Feb 8.

PMID:
29418021
8.

Assessing a multiplex-targeted proteomics approach for the clinical diagnosis of periodontitis using saliva samples.

Mertens B, Orti V, Vialaret J, Gibert P, Relaño-Ginés A, Lehmann S, de Périère DD, Hirtz C.

Bioanalysis. 2018 Jan;10(1):35-45. doi: 10.4155/bio-2017-0218. Epub 2017 Dec 15.

PMID:
29243487
9.

Impact of iron deficiency diagnosis using hepcidin mass spectrometry dosage methods on hospital stay and costs after a prolonged ICU stay: Study protocol for a multicentre, randomised, single-blinded medico-economic trial.

Lasocki S, Puy H, Mercier G, Lehmann S; Hepcidane study group.

Anaesth Crit Care Pain Med. 2017 Dec;36(6):391-396. doi: 10.1016/j.accpm.2017.04.009. Epub 2017 Sep 14.

PMID:
28919067
10.

Towards a routine application of Top-Down approaches for label-free discovery workflows.

Schmit PO, Vialaret J, Wessels HJCT, van Gool AJ, Lehmann S, Gabelle A, Wood J, Bern M, Paape R, Suckau D, Kruppa G, Hirtz C.

J Proteomics. 2018 Mar 20;175:12-26. doi: 10.1016/j.jprot.2017.08.003. Epub 2017 Aug 30.

PMID:
28855124
11.

Clinical perspectives of dried blood spot protein quantification using mass spectrometry methods.

Lehmann S, Picas A, Tiers L, Vialaret J, Hirtz C.

Crit Rev Clin Lab Sci. 2017 May;54(3):173-184. doi: 10.1080/10408363.2017.1297358. Epub 2017 Apr 10. Review.

PMID:
28393579
12.

Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.

Gabelle A, Jaussent I, Hirtz C, Vialaret J, Navucet S, Grasselli C, Robert P, Lehmann S, Dauvilliers Y.

Neurobiol Aging. 2017 May;53:59-66. doi: 10.1016/j.neurobiolaging.2017.01.011. Epub 2017 Jan 18.

PMID:
28235679
13.

Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS.

Delaby C, Bros P, Vialaret J, Moulinier A, Delatour V, Gabelle A, Lehmann S, Hirtz C.

Bioanalysis. 2017 Feb;9(4):337-347. doi: 10.4155/bio-2016-0240. Epub 2017 Jan 20.

PMID:
28106476
14.

Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?

Lehmann S, Brede C, Lescuyer P, Cocho JA, Vialaret J, Bros P, Delatour V, Hirtz C; IFCC Working Group on Clinical Quantitative Mass Spectrometry Proteomics (WG-cMSP).

Clin Chim Acta. 2017 Apr;467:51-58. doi: 10.1016/j.cca.2016.06.001. Epub 2016 Jun 2. Review.

PMID:
27265523
15.

Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis.

Hassan D, Provansal M, Lehmann S, Rizk M, Moez P, Vialaret J, Hirtz C, Essa A, Agamia H.

Br J Biomed Sci. 2016 Jul;73(3):143-146. Epub 2016 Jun 2. No abstract available.

PMID:
27254308
16.

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid.

Hirtz C, Vialaret J, Gabelle A, Nowak N, Dauvilliers Y, Lehmann S.

Sci Rep. 2016 May 11;6:25162. doi: 10.1038/srep25162.

17.

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

Barthélemy NR, Gabelle A, Hirtz C, Fenaille F, Sergeant N, Schraen-Maschke S, Vialaret J, Buée L, Junot C, Becher F, Lehmann S.

J Alzheimers Dis. 2016;51(4):1033-43. doi: 10.3233/JAD-150962.

PMID:
26923020
18.

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

Barthélemy NR, Fenaille F, Hirtz C, Sergeant N, Schraen-Maschke S, Vialaret J, Buée L, Gabelle A, Junot C, Lehmann S, Becher F.

J Proteome Res. 2016 Feb 5;15(2):667-76. doi: 10.1021/acs.jproteome.5b01001. Epub 2016 Jan 19.

PMID:
26742856
19.

Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.

Hirtz C, Vialaret J, Nouadje G, Schraen S, Benlian P, Mary S, Philibert P, Tiers L, Bros P, Delaby C, Gabelle A, Lehmann S.

Clin Chim Acta. 2016 Feb 15;454:33-8. doi: 10.1016/j.cca.2015.12.020. Epub 2015 Dec 19.

PMID:
26707914
20.

Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS.

Hirtz C, Vialaret J, Nowak N, Gabelle A, Deville de Périère D, Lehmann S.

Bioanalysis. 2016;8(1):43-53. doi: 10.4155/bio.15.228. Epub 2015 Dec 9.

PMID:
26647646

Supplemental Content

Loading ...
Support Center